Cibus Inc. Plunges 15.68% on Stock Offering

On June 5, 2025, Cibus Inc. (NASDAQ: CBUS) experienced a significant drop of 15.68% in pre-market trading, reflecting a notable decline in its stock price.

Cibus Inc. has announced its intention to offer Class A common stock publicly. This move is aimed at raising funds for the development of plant traits and general corporate purposes. The company, which specializes in gene editing for plant traits, is seeking to leverage this offering to support its ongoing research and development efforts.

Cibus Inc. has also announced a strategic realignment to streamline its operations and focus on key commercial opportunities. This realignment includes a projected cost savings of approximately $10 million on an annualized basis, which is expected to reduce cash use by about 20%. The company aims to advance its weed management platform for rice, pod shatter reduction in canola, and sclerotinia resistance in canola through this strategic shift.

Additionally, Cibus Inc. has received regulatory approvals for its herbicide tolerance traits in Ecuador and the United States. These designations confirm the conventional regulation of Cibus' traits, paving the way for further product development and eventual commercialization. The company's progress in gene editing technologies and regulatory approvals are crucial for its future growth and market position.